Predicting pancreatic fistula (POPF) by preoperative ultrasound elastography (ARFI)

Pancreatology ◽  
2020 ◽  
Vol 20 ◽  
pp. S181
Author(s):  
V. Von Ehrlich-Treuenstaett ◽  
M. Ilmer ◽  
D. Clevert ◽  
H. Niess ◽  
J. D‘Haese ◽  
...  
Pancreas ◽  
2020 ◽  
Vol 49 (10) ◽  
pp. 1342-1347
Author(s):  
Giovanni Marasco ◽  
Claudio Ricci ◽  
Francesco Buttitta ◽  
Elton Dajti ◽  
Federico Ravaioli ◽  
...  

Pancreas ◽  
2020 ◽  
Vol 49 (6) ◽  
pp. 799-805
Author(s):  
Yusuke Kawabata ◽  
Toshihiro Okada ◽  
Hiroko Iijima ◽  
Masahiro Yoshida ◽  
Hideaki Iwama ◽  
...  

2015 ◽  
Vol 100 (3) ◽  
pp. 497-502 ◽  
Author(s):  
Masahide Hatano ◽  
Jota Watanabe ◽  
Fumiki Kushihata ◽  
Taiji Tohyama ◽  
Taira Kuroda ◽  
...  

“Soft pancreas” has often been reported as a predictive factor for postoperative pancreatic fistula (POPF) after pancreatectomy. However, pancreatic stiffness is judged subjectively by surgeons, without objective criteria. In the present study, pancreatic stiffness was quantified using intraoperative ultrasound elastography, and its relevance to POPF and histopathology was investigated. Forty-one patients (pancreatoduodenectomy, 30; distal pancreatectomy, 11) who underwent intraoperative elastography during pancreatectomy were included. The elastic ratio was determined at the pancreatic resection site (just above the portal vein) and at the remnant pancreas (head or tail). Correlations between the incidence of POPF and patient characteristics, operative variables, and the elastic ratio were examined. In addition, the relationship between the elastic ratio and the percentage of the exocrine gland at the resection stump was investigated. For pancreatoduodenectomy patients, main pancreatic duct diameter < 3.2 mm and elastic ratio < 2.09 were significant risk factors for POPF. In addition, the elastic ratio, but not main pancreatic duct diameter, was significantly associated with the percentage of exocrine gland area at the pancreatic resection stump. Pancreatic stiffness can be quantified using intraoperative elastography. Elastography can be used to diagnose “soft pancreas” and may thus be useful in predicting the occurrence of POPF.


2017 ◽  
Vol 35 (2) ◽  
pp. 164-170 ◽  
Author(s):  
Mirko D'Onofrio ◽  
Giulia Tremolada ◽  
Riccardo De Robertis ◽  
Stefano Crosara ◽  
Valentina Ciaravino ◽  
...  

2018 ◽  
Vol 3 (2) ◽  

Introduction: BTL EMSELLA™ utilizes High-Intensity Focused Electromagnetic technology (HIFEM) to cause deep pelvic floor muscles stimulation and restoration of the neuromuscular control. Key effectiveness is based on focused electromagnetic energy, in-depth penetration and stimulation of the entire pelvic floor area. A single BTL EMSELLA™ session brings thousands of supramaximal pelvic floor muscle contractions, which are extremely important in muscle reeducation of incontinent patients. Objective: Prospective study to evaluate the safety and preliminary effectiveness of the use of BTL EMSELLA magnetic stimulation in urinary incontinence. Method: Thirty-two patients with light and moderate urinary incontinence were recruited to perform 6 sessions of BTL EMSELLA during three weeks of initial treatment. Follow-up after three months. The patients received sessions lasting 28 minutes, completing the different treatment protocols. Initially the patients underwent a quality of life test before and after treatment, evaluation with advanced ultrasound using elastography to measure the initial tissue's elasticity and be able to compare after treatment, clinical functional evaluation and urodynamic test. Results: No adverse reactions were observed. All the patients finished the treatment sessions. Two patients reported increased pain after treatment in the first session corresponding to a VAS scale greater than 5 with duration greater than three hours. The treatment was highly satisfactory in 84,4% of the patients. After the first three months the improvement was maintained in 77% of the patients. No muscle injuries were observed. Elastographic changes and improvement of muscle tone were detected by advanced ultrasound (elastography) in 100% of patients. Conclusions: BTL EMSELLA is safe, well tolerated and effective for the treatment of mild and moderate urinary incontinence. The observed elastographic changes demonstrate the improvement of pelvic floor muscle tone after treatment. A reduction in the symptoms of urinary incontinence was demonstrated. Recommendations: Continue increasing the number of cases for research and increase the variables that we have decided to incorporate in the next research section such as MRI and pressure calculation.


Sign in / Sign up

Export Citation Format

Share Document